A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT02042950 · TERMINATED
Trial details
- NCT number
- NCT02042950
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-14
- Primary completion
- 2017-12-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.